Mary C. Conrad

Statistics

Publications

Citations

364

H-Index

Active since

2020

Affiliations

California Institute of Technology(Current)

Nanotherapeutics (United States)

Massachusetts General Hospital

University of California, Davis

Mary C. Conrad is an author at California Institute of Technology specializing in autism spectrum disorders, pediatric immune dysregulation, and disease metabolite profiling.

Publications per year

2020–2022

Publications

Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder

Brittany D. Needham, Mark D. Adame, Gloria Serena et al. · Biological Psychiatry · 2020 · 236 citations · Full text

Life Sciences, Biochemistry, Nutrition +17

Safety and target engagement of an oral small-molecule sequestrant in adolescents with autism spectrum disorder: an open-label phase 1b/2a trial

A. Stewart Campbell, Brittany D. Needham, Christopher R. Meyer et al. · Nature Medicine · 2022 · 105 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +8

Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder

Brittany D. Needham, Mark D. Adame, Gloria Serena et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 23 citations · Full text

Life Sciences, Biochemistry, Nutrition +17

1–3 of 3